Recent advances in management of gout
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Jung Soo | - |
dc.date.available | 2019-03-08T12:59:33Z | - |
dc.date.issued | 2016-05 | - |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.issn | 2093-5951 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/6989 | - |
dc.description.abstract | Gout, which is caused by the deposition of monosodium urate crystals in synovial fluid and other tissues, is the most common inflammatory rheumatic disease in men, at least in the Western world, and is increasing in prevalence worldwide. In addition to extremely painful recurrent acute and chronic arthritis, gout is associated with chronic kidney diseases and metabolic syndrome, including dyslipidemia, hypertension, hyperglycemia, and obesity. Thus it has an impact on morbidity and premature mortality. For the proper management of gout, definite diagnosis should come first. Management plans for the treatment of gout have to be designed to meet the requirements of each individual patient and to control both gout and its associated disorders. The goals of treatment for gout are fast pain relief and the prevention of future gout attacks and long-term complications, such as joint destruction and other comorbidities. In this article, recent advanced non-pharmacologic and pharmacologic management strategies for gout and hyperuricemia will be described. | - |
dc.format.extent | 6 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | KOREAN MEDICAL ASSOC | - |
dc.title | Recent advances in management of gout | - |
dc.type | Article | - |
dc.identifier.doi | 10.5124/jkma.2016.59.5.379 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, v.59, no.5, pp 379 - 384 | - |
dc.identifier.kciid | ART002107916 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84969902440 | - |
dc.citation.endPage | 384 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 379 | - |
dc.citation.title | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.citation.volume | 59 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Gout | - |
dc.subject.keywordAuthor | Uric acid | - |
dc.subject.keywordAuthor | Hyperuricemia | - |
dc.subject.keywordAuthor | Management | - |
dc.subject.keywordPlus | OF-RHEUMATOLOGY GUIDELINES | - |
dc.subject.keywordPlus | AMERICAN-COLLEGE | - |
dc.subject.keywordPlus | HYPERURICEMIA | - |
dc.subject.keywordPlus | ALLOPURINOL | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | HLA-B-ASTERISK-5801 | - |
dc.subject.keywordPlus | REDUCTION | - |
dc.subject.keywordPlus | ARTHRITIS | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.